Growth Metrics

aTYR PHARMA (ATYR) Other Gross PP&E Adjustments (2019 - 2025)

aTYR PHARMA (ATYR) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 81.54% year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Dec 2025, down 81.54%, and an annual FY2025 reading of $1.1 million, down 81.54% over the prior year.
  • Other Gross PP&E Adjustments was $1.1 million for Q4 2025 at aTYR PHARMA, up from -$5.6 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $6.2 million in Q4 2024 and bottomed at -$7.0 million in Q3 2022.
  • Average Other Gross PP&E Adjustments over 5 years is -$1.3 million, with a median of -$1.4 million recorded in 2021.
  • The sharpest move saw Other Gross PP&E Adjustments plummeted 371.33% in 2022, then skyrocketed 284.98% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at $5.3 million in 2021, then crashed by 89.96% to $535000.0 in 2022, then surged by 199.81% to $1.6 million in 2023, then surged by 284.98% to $6.2 million in 2024, then tumbled by 81.54% to $1.1 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for ATYR at $1.1 million in Q4 2025, -$5.6 million in Q3 2025, and -$894000.0 in Q2 2025.